Page last updated: 2024-10-26

dipyridamole and Polychondritis, Chronic Atrophic

dipyridamole has been researched along with Polychondritis, Chronic Atrophic in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
"Relapsing polychondritis is rare and its cause is unknown."1.26Relapsing polychondritis with crescentic glomerulonephritis. ( Cameron, JS; Lessof, MH; Neild, GH; Ogg, CS; Turner, DR, 1978)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neild, GH1
Cameron, JS1
Lessof, MH1
Ogg, CS1
Turner, DR1

Other Studies

1 other study available for dipyridamole and Polychondritis, Chronic Atrophic

ArticleYear
Relapsing polychondritis with crescentic glomerulonephritis.
    British medical journal, 1978, Mar-25, Volume: 1, Issue:6115

    Topics: Adult; Aged; Azathioprine; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis; Huma

1978